As a beneficial and well-tolerated therapeutic option in advanced soft tissue sarcoma, experts sayYondeli the new cancer drug of marine origin by the biopharmaceutical company PharmaMar is developed as a useful and well-tolerated therapeutic option for patients with advanced profiling soft tissue sarcoma after failure of conventional treatment. This is the main conclusion of the symposium at the European Cancer Conference in Barcelona celebrated under the title of: improving the therapeutic results in soft tissue sarcoma: Can we do more?.
Between 2008 and 2010, approximately 16,000 people older than older than 16 (mean age 46, studied in terms of their soda consumption, which South Australian South Australian monitoring and Surveillance System, the researchers found that 1 in 10 people at least half. Liters of carbonated drinks per day or drink.Cervical cancer protection protect HPV vaccination female Dr. Eduardo Franco, CIHR -funded research of McGill University .
Immunization against hepatitis A could for improvement in public health among adults in Canada Dr. David Scheifele, CIHR financed by researcher in British Columbia Children’s Hospital .